PROF.US Profound Medical Corp

Healthcare Health Care Equipment & Supplies USA Stocks
7.08 USD
Close of Nov 18, 2026
4.80 8.95
Market cap
USD 259M
P/E
-
P/B
6.33x
ROE
-76.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PROF.US undervalued?

Graham number

The Graham number of Profound Medical Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Profound Medical Corp fundamental analysis

No fundamental analysis for Profound Medical Corp yet.

Profound Medical Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Profound Medical Corp

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or be…

Full company profile